Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H17NO2.ClH |
| Molecular Weight | 255.741 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@@]1(CCCCN1)[C@H](C(O)=O)C2=CC=CC=C2
InChI
InChIKey=SCUMDQFFZZGUQY-MNMPKAIFSA-N
InChI=1S/C13H17NO2.ClH/c15-13(16)12(10-6-2-1-3-7-10)11-8-4-5-9-14-11;/h1-3,6-7,11-12,14H,4-5,8-9H2,(H,15,16);1H/t11-,12-;/m1./s1
Ritalinic acid is an inactive, major metabolite of methylphenidate, a schedule II drug in the United States commonly used as a psychostimulant drugs methylphenidate and ethylphenidate. The elimination half-life of methylphenidate is relatively short (approximately 2 hours); therefore it is also available in extended release (ER) forms. The main metabolite is ritalinic acid, and the methylphenidate metabolites are mostly excreted in urine.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
19395-40-5
Created by
admin on Sat Dec 16 09:14:48 GMT 2023 , Edited by admin on Sat Dec 16 09:14:48 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
1382859-13-3
Created by
admin on Sat Dec 16 09:14:48 GMT 2023 , Edited by admin on Sat Dec 16 09:14:48 GMT 2023
|
PRIMARY | |||
|
2IEY1KK135
Created by
admin on Sat Dec 16 09:14:48 GMT 2023 , Edited by admin on Sat Dec 16 09:14:48 GMT 2023
|
PRIMARY | |||
|
49801997
Created by
admin on Sat Dec 16 09:14:48 GMT 2023 , Edited by admin on Sat Dec 16 09:14:48 GMT 2023
|
PRIMARY | |||
|
1434022
Created by
admin on Sat Dec 16 09:14:48 GMT 2023 , Edited by admin on Sat Dec 16 09:14:48 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
